Glenmark Pharma’s US Division Unveils Lacosamide Oral Solution for Seizure Management
Glenmark Pharmaceuticals Ltd announced on Monday, December 16, that its U.S. subsidiary has launched Lacosamide Oral Solution, 10 mg/mL, an…
US Division
Read More